Search Result "Partial PPARγ agonists"
A Review on the Development in the Field of NIDDM based Thiazolidinedione PPARγ Agonists
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 13 Issue: 5 Year: 2013 Page: 706-712
Author(s): Pooja S. Banerjee, Subir Samanta
Balaglitazone: A Second Generation Peroxisome Proliferator-Activated Receptor (PPAR) Gamma (γ) Agonist
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 12 Issue: 2 Year: 2012 Page: 87-97
Author(s): R. Agrawal, P. Jain, S. N. Dikshit
From Dual Peroxisome Proliferator Activated Receptor Agonists to Selective Peroxisome Proliferator Activated Receptor Modulators
Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 2 Issue: 1 Year: 2008 Page: 24-28
Author(s): Selcuk Dagdelen
Virtual Screening, Docking, Synthesis and Bioactivity Evaluation of Thiazolidinediones as Potential PPARγ Partial Agonists for Preparation of Antidiabetic Agents
Journal: Letters in Drug Design & Discovery
Volume: 16 Issue: 6 Year: 2019 Page: 608-617
Author(s): Beina Zhang,Mao Shu,Chunmei Xu,Chunhong An,Rui Wang,Zhihua Lin
Retinoid X Receptor Ligands with Anti-Type 2 Diabetic Activity
Journal: Current Topics in Medicinal Chemistry
Volume: 17 Issue: 6 Year: 2017 Page: 696-707
Author(s): Ken-ichi Morishita,Hiroki Kakuta
Docking, Synthesis and Anti-Diabetic Activity of Novel Sulfonylhydrazone Derivatives Designed as PPAR-Gamma Agonists
Journal: Current Topics in Medicinal Chemistry
Volume: 12 Issue: 19 Year: 2012 Page: 2037-2048
Author(s): Gisele Zapata-Sudo,Lidia M. Lima,Sharlene L. Pereira,Margarete M. Trachez,Filipe P. da Costa,Beatriz J. Souza,Carlos E. S. Monteiro,Nelilma C. Romeiro,Everton D. D’Andrea,Roberto T. Sudo,Eliezer J. Barreiro
Hydroxy Cinnamic Acid Derivatives as Partial PPARγ Agonists: In silico Studies, Synthesis and Biological Characterization Against Chronic Myeloid Leukemia Cell Line (K562)
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17 Issue: 4 Year: 2017 Page: 524-541
Author(s): Hardik Joshi,Kavita Marulkar,Vikram Gota,C. S. Ramaa
Peroxisome Proliferator-Activated Receptor (PPAR) Gamma Agonists as Therapeutic Agents for Cardiovascular Disorders: Focus on Atherosclerosis
Journal: Current Pharmaceutical Design
Volume: 23 Issue: 7 Year: 2017 Page: 1119-1124
Author(s): Ekaterina A. Ivanova,Veronika A. Myasoedova,Alexandra A. Melnichenko,Alexander N. Orekhov
Design and Development of Oxazol-5-Ones as Potential Partial PPAR-γ Agonist Against Cancer Cell Lines
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14 Issue: 6 Year: 2014 Page: 872-883
Author(s): Tanushree Pal,Hardik Joshi,C.S. Ramaa
The Role of Peroxisome Proliferator-Activated Receptor-γ in Breast Cancer
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12 Issue: 9 Year: 2012 Page: 1025-1044
Author(s): Ioly Kotta-Loizou,Constantinos Giaginis,Stamatios Theocharis